FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Wesseling

Research Profile

Living Beings

Procedures

Genetic Therapy

Chemicals & Drugs

Anatomy

Disorders

Physiology

Transduction, Genetic

Devices

Gene Transfer Techniques

Co-author Network

Publications

TOP 3
Joyce Lübbers; Solbritt Rantapää-Dahlqvist; Lotte A van de Stadt; Dirkjan van Schaardenburg; Saskia Vosslamber; John G Wesseling; Mikael Brink; Cornelis L Verweij
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis.
Michael A Van Geer; Daniel Brevoord; Koert F D Kuhlmann; Conny T Bakker; Hiroyuki Mizuguchi; John G Wesseling; Fibo J Ten Kate; Dirk J Gouma; Ronald P J Oude Elferink; Piter J Bosma
A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
K F D Kuhlmann; M A van Geer; C T Bakker; J E M Dekker; M J E Havenga; R P J Oude Elferink; Dirk J Gouma; Piter J Bosma; John G Wesseling
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Wesseling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joyce Lübbers; Solbritt Rantapää-Dahlqvist; Lotte A van de Stadt; Dirkjan van Schaardenburg; Saskia Vosslamber; John G Wesseling; Mikael Brink; Cornelis L Verweij
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis.
Annals of the rheumatic diseases 2013;72(5):776-80.
2010: Michael A Van Geer; Daniel Brevoord; Koert F D Kuhlmann; Conny T Bakker; Hiroyuki Mizuguchi; John G Wesseling; Fibo J Ten Kate; Dirk J Gouma; Ronald P J Oude Elferink; Piter J Bosma
A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
International journal of oncology 2010;36(1):233-44.
2009: K F D Kuhlmann; M A van Geer; C T Bakker; J E M Dekker; M J E Havenga; R P J Oude Elferink; Dirk J Gouma; Piter J Bosma; John G Wesseling
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
Cancer gene therapy 2009;16(7):585-97.
2007: Willem A Marsman; John G Wesseling; Abelkarim El Bouch; Piter J Bosma; J J B van Lanschot
Adenoviral serotypes in gene therapy for esophageal carcinoma.
The Journal of surgical research 2007;140(1):50-4.
2006: Michael Lie-A-Ling; Conny T Bakker; Tanja Deurholt; Ruurdtje Hoekstra; John G Wesseling; Simon C Afford; Piter J Bosma
Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.
Journal of hepatology 2006;44(1):126-33.
2005: Willem A Marsman; Christianne J Buskens; John G Wesseling; J J B van Lanschot; Piter J Bosma
Gene therapy for barrett's esophagus: adenoviral gene transfer in different intestinal models.
Cancer gene therapy 2005;12(9):778-86.
2005: M Lie-A-Ling; Conny T Bakker; John G Wesseling; Piter J Bosma
AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
Gene therapy 2005;12(17):1347-52.
2004: Willem A Marsman; Christianne J Buskens; John G Wesseling; G Johan A Offerhaus; Jacques J G H M Bergman; G N J Tytgat; J J B van Lanschot; Piter J Bosma
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.
Cancer gene therapy 2004;11(4):289-96.
2004: K F D Kuhlmann; S M M de Castro; John G Wesseling; Fiebo J W Ten Kate; G Johan A Offerhaus; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
European journal of cancer (Oxford, England : 1990) 2004;40(4):549-58.
2004: Alexandra M Pietersen; Saskia A Rutjes; Joost van Tongeren; Ronald Vogels; John G Wesseling; Mathieu H M Noteborn
The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells.
Journal of molecular medicine (Berlin, Germany) 2004;82(1):56-63.
2003: Christianne J Buskens; Willem A Marsman; John G Wesseling; G Johan A Offerhaus; Masato Yamamoto; David T Curiel; Piter J Bosma; J J B van Lanschot
A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.
Annals of surgery 2003;238(6):815-24; discussion 825-6.
2003: Saskia A Rutjes; Piter J Bosma; Jennifer L Rohn; Mathieu H M Noteborn; John G Wesseling
Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Journal of molecular medicine (Berlin, Germany) 2003;81(9):558-65.
2001: John G Wesseling; M Yamamoto; Y Adachi; Piter J Bosma; M van Wijland; Jerry L Blackwell; H Li; Paul N Reynolds; Igor Dmitriev; Selwyn M Vickers; K Huibregtse; David T Curiel
Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma.
Cancer gene therapy 2001;8(12):990-6.
2001: John G Wesseling; Piter J Bosma; Victor Krasnykh; Elena Kashentseva; Jerry L Blackwell; Paul N Reynolds; H Li; M Parameshwar; Selwyn M Vickers; Elizabeth M Jaffee; K Huibregtse; David T Curiel; Igor Dmitriev
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
Gene therapy 2001;8(13):969-76.